TP53 and prostate carcinoma: Pathway analysis of differentially expressed mRNAs (Figure 6, Supplementary Table S8) showed that they were involved in the cell cycle, P53 signaling pathway, prostate cancer, thyroid cancer, and endometrial cancer, Wnt signaling pathway, glioma, bladder cancer, pancreatic cancer, and axon guidance.